LENZ Therapeutics, Inc. (LENZ)
NASDAQ: LENZ · Real-Time Price · USD
13.49
-0.03 (-0.22%)
At close: Feb 27, 2026, 4:00 PM EST
13.23
-0.26 (-1.93%)
After-hours: Feb 27, 2026, 7:53 PM EST
LENZ Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Feb '26 Feb 27, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 422 | 794 | - | - | - |
| Enterprise Value | 221 | 578 | - | - | - |
| Last Close Price | 13.49 | 28.87 | - | - | - |
| PB Ratio | 1.99 | 3.89 | - | - | - |
| P/TBV Ratio | 2.18 | 3.89 | - | - | - |
| Debt / Equity Ratio | 0.01 | 0.01 | 0.01 | 0.01 | - |
| Net Debt / Equity Ratio | -1.04 | -1.02 | -1.27 | -1.19 | -1.07 |
| Net Debt / EBITDA Ratio | 2.97 | 3.55 | 0.90 | 4.22 | 2.74 |
| Net Debt / FCF Ratio | 4.36 | 3.47 | 1.08 | 10.71 | 3.39 |
| Asset Turnover | 0.08 | - | - | 0.46 | - |
| Quick Ratio | 12.46 | 20.09 | 3.55 | 4.68 | 14.61 |
| Current Ratio | 12.69 | 20.36 | 3.63 | 4.91 | 14.62 |
| Return on Equity (ROE) | -28.78% | -38.94% | -157.61% | -39.80% | - |
| Return on Assets (ROA) | -19.52% | -25.64% | -77.17% | -20.07% | - |
| Return on Capital Employed (ROCE) | -34.90% | -28.60% | -139.70% | -28.00% | -39.20% |
| Earnings Yield | -13.95% | -6.27% | - | - | - |
| FCF Yield | -10.94% | -7.54% | - | - | - |
| Buyback Yield / Dilution | -87.55% | -986.27% | 79.28% | -1.05% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.